Interestingly, some studies with a sample size lower than ours but on a different drug protocol have shown that MDR1 overexpression correlated with lower CR and higher relapse rates in acute leukemia (AL) (n = 44)7 and with reduced DFS in acute lymphoblastic leukemia (ALL) patients treated with ALL-BFM 95 protocol (n = 49)19. Here, ABCB1 is linked to acute leukemia.